Deepinder Goyal’s Temple’s Valuation Doubles To $375 Mn: Report

Former Eternal CEO Deepinder Goyal’s wearable startup Temple has reportedly almost doubled its valuation to $375 Mn and launched its first employee stock ownership plan (ESOP) liquidity programme, allowing some early employees to sell a portion of their vested stock options. 

According to a Moneycontrol report, around 20 employees from Temple’s workforce of 200-220 will be eligible to sell up to 25% of their vested ESOPs under the programme. 

Citing an internal memo, the publication said the buyback values the startup at $375 Mn, nearly double the $190 Mn valuation at which it raised a $54 Mn seed funding round in February this year. 

The report said Goyal told employees that Temple has been receiving interest from external investors at a valuation of about $500 Mn ahead of its next funding round. However, the startup chose to conduct the ESOP liquidity event at the lower $375 Mn valuation to allow employees to benefit before the next raise. 

“We are offering all eligible employees the option to sell up to 25% of their vested ESOPs at a $375 Mn valuation. This is completely optional,” Goyal was quoted as saying. 

Temple declined to comment on Inc42’s queries on the development.

Temple offers a forehead-worn wearable designed to measure the body’s metabolic state in real time. The startup is currently offering the device through an early access programme and is working towards a broader commercial launch. It has partnered with Ethereal Machines and Zetwerk for manufacturing. 

Temple raised $54 Mn earlier this year from Steadview Capital, Peak XV Partners, Vy Capital and Info Edge, alongside several founder-investors and early employees. Regulatory filings showed Goyal owns about 28% of the startup, while employees collectively hold around 10% through ESOPs. 

Temple is closely associated with Goyal’s longevity-focused initiative Continue Research. Last year, the research group published a hypothesis suggesting that reduced cerebral blood flow caused by gravity could be an overlooked factor in human ageing, triggering debate among researchers and medical experts over its scientific validity. 

Goyal maintained that even if the hypothesis does not ultimately prove correct, Temple’s wearable could still succeed as a standalone consumer health device. 

The startup’s latest valuation milestone comes as investor interest in preventive healthcare and longevity technologies continues to grow. Indian startups such as Ultrahuman, Gabit and FITTR have expanded beyond conventional fitness tracking into broader health monitoring, while newer companies are developing AI-powered wearables and specialised sensors amid rising consumer demand for personalised health insights. 

The post Deepinder Goyal’s Temple’s Valuation Doubles To $375 Mn: Report appeared first on Inc42 Media.